A. Philis-Tsimikas Et Al. , "Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.," Diabetes research and clinical practice , vol.147, pp.157-165, 2019
Philis-Tsimikas, A. Et Al. 2019. Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.. Diabetes research and clinical practice , vol.147 , 157-165.
Philis-Tsimikas, A., Astamirova, K., Gupta, Y., Haggag, A., Roula, D., Bak, B. A., ... Fita, E. G.(2019). Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.. Diabetes research and clinical practice , vol.147, 157-165.
Philis-Tsimikas, A. Et Al. "Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.," Diabetes research and clinical practice , vol.147, 157-165, 2019
Philis-Tsimikas, A. Et Al. "Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.." Diabetes research and clinical practice , vol.147, pp.157-165, 2019
Philis-Tsimikas, A. Et Al. (2019) . "Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.." Diabetes research and clinical practice , vol.147, pp.157-165.
@article{article, author={A. Philis-Tsimikas Et Al. }, title={Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus.}, journal={Diabetes research and clinical practice}, year=2019, pages={157-165} }